Houssein Abdul Sater Selected Research

Vaccines

11/2022	A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer.
1/2021	Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune-Tumor Interactions: Engage, Expand, Enable.
1/2021	Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC).
1/2020	Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Houssein Abdul Sater Research Topics

Disease

9	Neoplasms (Cancer) 12/2021 - 01/2019
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2019
3	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024
1	Colorectal Neoplasms (Colorectal Cancer) 11/2022
1	Inflammation (Inflammations) 01/2022
1	Obesity 01/2022
1	Residual Neoplasm 12/2021
1	Papilloma (Papillomatosis) 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020
1	Carcinogenesis 01/2019

Drug/Important Bio-Agent (IBA)

4	VaccinesIBA 11/2022 - 01/2020
2	avelumabIBA 11/2022 - 01/2021
2	Chimeric Antigen ReceptorsIBA 01/2021 - 01/2020
2	AntigensIBA 01/2021 - 01/2020
1	LigandsIBA 03/2024
1	Biomarkers (Surrogate Marker)IBA 03/2024
1	Proteins (Proteins, Gene)FDA Link 03/2024
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2024
1	Bevacizumab (Avastin)FDA Link 11/2022
1	Estrogens (Estrogen)FDA Link 01/2022
1	disodium (R,R)- 5- (2- ((2- (3- chlorophenyl)- 2- hydroxyethyl)- amino)propyl)- 1,3- benzodioxole- 2,3- dicarboxylateIBA 01/2022
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2022
1	AntioxidantsIBA 01/2022
1	Thioctic Acid (Lipoic Acid)IBA 01/2022
1	Progesterone FDA LinkGeneric 01/2022
1	enzalutamideIBA 12/2021
1	DNA (Deoxyribonucleic Acid)IBA 12/2021
1	AndrogensIBA 12/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2021
1	Interleukin-15 (Interleukin 15)IBA 01/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	ALT-803IBA 01/2021
1	Brachyury protein (Brachyury)IBA 01/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2021
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2020
1	PROSTVACIBA 01/2020
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2019
1	NIMA-Related KinasesIBA 01/2019
1	CytokinesIBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Myosins (Myosin)IBA 01/2019
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019

Therapy/Procedure

5	Immunotherapy 11/2022 - 01/2019
2	Therapeutics 12/2021 - 01/2021
2	Aftercare (After-Treatment) 12/2021 - 01/2021
1	Castration 01/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Prostatectomy (Retropubic Prostatectomy) 01/2020